Sofia Michael J. 4/A
4/A · Arbutus Biopharma Corp · Filed Aug 15, 2018
Insider Transaction Report
Form 4/AAmended
Sofia Michael J.
Chief Scientific Officer
Transactions
- Sale
Common Shares
2018-08-13$9.51/sh−4,250$40,436→ 167,162 total(indirect: By Trust)
Holdings
- 1,503,403
Common Shares
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.5073 to $9.5525, inclusive. The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.